We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

40 hedge funds and large institutions have $9.89M invested in Dare Bioscience in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

5% more funds holding

Funds holding: 38 → 40 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.03% less ownership

Funds ownership: 0.75% → 0.72% (-0.03%)

28% less capital invested

Capital invested by funds: $13.7M → $9.89M (-$3.85M)

Holders
40
Holders Change
+2
Holders Change %
+5.26%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
12
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$625K
2
SAM
Soviero Asset Management
New York
+$473K
3
Millennium Management
Millennium Management
New York
+$403K
4
BlackRock
BlackRock
New York
+$369K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$340K

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$2.07M
2
Goldman Sachs
Goldman Sachs
New York
-$493K
3
Two Sigma Investments
Two Sigma Investments
New York
-$310K
4
FFS
Founders Financial Securities
Maryland
-$207K
5
CSS
Cubist Systematic Strategies
Connecticut
-$155K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$34K +$35.5K +1,878 New
Osaic Holdings
27
Osaic Holdings
Arizona
$31K +$6.3K +333 +24%
UCFA
28
United Capital Financial Advisors
Texas
$22K – – –
ASN
29
Advisory Services Network
Georgia
$22K +$23.6K +1,250 New
Squarepoint
30
Squarepoint
New York
$17K +$18.3K +968 New
IA
31
IFS Advisors
Kansas
$16K – – –
Victory Capital Management
32
Victory Capital Management
Texas
$13K +$1.38K +73 +8%
UBS Group
33
UBS Group
Switzerland
$8K -$15.5K -822 -65%
PNC Financial Services Group
34
PNC Financial Services Group
Pennsylvania
$4K – – –
Wells Fargo
35
Wells Fargo
California
$4K +$3.21K +170 +472%
APA
36
American Portfolios Advisors
New York
$1.49K – – –
AWA
37
Artemis Wealth Advisors
New York
$1.31K – – –
HNWAG
38
High Net Worth Advisory Group
Florida
$1K – – –
TIM
39
Tortoise Investment Management
New York
$1K – – –
Goldman Sachs
40
Goldman Sachs
New York
– -$493K -20,551 Closed
Two Sigma Investments
41
Two Sigma Investments
New York
– -$310K -12,927 Closed
FFS
42
Founders Financial Securities
Maryland
– -$207K -8,625 Closed
CSS
43
Cubist Systematic Strategies
Connecticut
– -$155K -6,443 Closed
Morgan Stanley
44
Morgan Stanley
New York
– -$106K -5,585 -100%
HF
45
HRT Financial
New York
– -$96K -4,032 Closed
Two Sigma Advisers
46
Two Sigma Advisers
New York
– -$69K -2,867 Closed
PSIWM
47
Paradigm Strategies in Wealth Management
Minnesota
– -$45K -1,863 Closed
TSS
48
Two Sigma Securities
New York
– -$23K -968 Closed
EWM
49
Edge Wealth Management
New York
– -$4K -167 Closed
NL
50
NVWM LLC
Pennsylvania
– -$1K -43 Closed
1
2

DARE Hedge Fund Activity: Q1 2022 in Review

40 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2022, worth a combined $9.89M — down 28% from $13.7M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new DARE positions and 10 closed out — a net gain of 2 holders — while 12 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $625K. The largest seller was Marshall Wace, cutting an estimated $2.07M.

  • 40 institutional investors held Dare Bioscience (DARE) as of Q1 2022, up from 38 in Q4 2021.
  • Funds reported $9.89M of Dare Bioscience stock for Q1 2022, down 28% quarter-over-quarter.
  • 12 funds opened new Dare Bioscience positions in Q1 2022 and 10 closed out, a net change of +2 holders.
  • The largest Dare Bioscience buyer in Q1 2022 was Vanguard Group, an estimated $625K added.
  • The largest Dare Bioscience seller in Q1 2022 was Marshall Wace, an estimated $2.07M sold.

Based on aggregated 13F filings for Q1 2022.